Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Multiple Sclerosis
University Medical Center, Department of Rehabilitation Medicine details research in multiple sclerosis
April 11th, 2007
Research findings, "Cross-diagnostic validity of the SF-36 physical functioning scale in patients with stroke, multiple sclerosis and amyotrophic lateral sclerosis: a study using Rasch analysis," are discussed in a new report. "The aim of this study was to investigate unidimensionality and differential item functioning of the SF-36 physical functioning scale (PF10) in patients with various neurological disorders. Patients post-stroke (n=198), with multiple sclerosis (n=151) and amyotrophic lateral sclerosis (n=193) participated. Unidimensionality of the PF10 within the patient groups was investigated by performing a separate Rasch analysis for each group," researchers in Amsterdam,...
Source: Immunotherapy Weekly (2007-04-11)
|
